Litenimod
Litenimod is potent type B agonist of toll Like receptor 9 (TLR9), triggering both innate and adaptive immune response.
Product Specifications
CAS Number
[852313-25-8]
Product Name Alternative
Li28
UNSPSC
12352208
Target
Toll-like Receptor (TLR)
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
[Litenimod]
References & Citations
[1]Schaedler E, Remy-Ziller C, Hortelano J, et al. Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors. Vaccine. 2017;35 (4) :577-585.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
D1649-01D-HRP 200 µL
DDR1, ID (Epithelial Discoidin Domain-containing Receptor 1, Epithelial Discoidin Domain Receptor 1, Tyrosine Kinase DDR, Discoidin Receptor Tyrosine Kinase, Tyrosine-protein Kinase CAK, Cell Adhesion Kinase, TRK E, Protein-tyrosine Kinase 3A, Protein-tyrosine Kinase RTK 6, HGK2, CD167 Antigen-like Family Member A, Mammary Carcinoma Kinase 10, MCK-10, CD167a, DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE) (HRP) discontinued
Ask
View Details 
MBS6388152-01 0.1 mL
OXA1L (Mitochondrial Inner Membrane Protein OXA1L, Hsa, OXA1Hs, Oxidase Assembly 1-like Protein, OXA1-like Protein) APC
Ask
View Details MBS6388152-02 5x 0.1 mL
OXA1L (Mitochondrial Inner Membrane Protein OXA1L, Hsa, OXA1Hs, Oxidase Assembly 1-like Protein, OXA1-like Protein) APC
Ask
View Details 